Cargando…

The role of peptide YY in gastrointestinal diseases and disorders

Peptide YY (PYY) is affected in several gastrointestinal diseases and disorders. Changes in PYY appear to be an adaptive response to alterations in pathophysiological conditions caused by the disease. This applies to gastrointestinal diseases/disorders such as irritable bowel syndrome, inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	EL-SALHY, MAGDY, MAZZAWI, TAREK, GUNDERSEN, DORIS, HATLEBAKK, JAN GUNNAR, HAUSKEN, TRYGVE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042877/ https://www.ncbi.nlm.nih.gov/pubmed/23292145 http://dx.doi.org/10.3892/ijmm.2012.1222

Ejemplares similares

Interaction between diet and gastrointestinal endocrine cells
por: EL-SALHY, MAGDY, et al.
Publicado: (2016)

Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report
por: El-Salhy, Magdy, et al.
Publicado: (2013)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
por: El‐Salhy, Magdy, et al.
Publicado: (2022)

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome
por: MAZZAWI, TAREK, et al.
Publicado: (2014)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance
por: Mazzawi, Tarek, et al.
Publicado: (2015)

Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis
por: El-Salhy, Magdy, et al.
Publicado: (2012)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Low Densities of Serotonin and Peptide YY Cells in the Colon of Patients with Irritable Bowel Syndrome
por: El-Salhy, M., et al.
Publicado: (2011)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Density of Musashi-1-positive stem cells in the stomach of patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (Review)
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats
por: El-Salhy, Magdy, et al.
Publicado: (2014)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2018)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2021)

Stomach antral endocrine cells in patients with irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Dietary fiber in irritable bowel syndrome (Review)
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review)
por: Mazzawi, Tarek, et al.
Publicado: (2017)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Chromogranin A cell density in the rectum of patients with irritable bowel syndrome
por: EL-SALHY, M., et al.
Publicado: (2012)

Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2016)

Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome
por: Mazzawi, T, et al.
Publicado: (2015)

The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study
por: Mazzawi, Tarek, et al.
Publicado: (2022)

Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats
por: El-Salhy, Magdy, et al.
Publicado: (2016)

Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance
por: MAZZAWI, TAREK, et al.
Publicado: (2016)

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome
por: Mazzawi, Tarek, et al.
Publicado: (2016)

Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance
por: Mazzawi, Tarek, et al.
Publicado: (2017)

Nutritional Management of Gastrointestinal Diseases and Disorders
por: El-Salhy, Magdy
Publicado: (2019)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Abnormalities in endocrine and immune cells are correlated in dextran-sulfate-sodium-induced colitis in rats
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome
por: EL-SALHY, MAGDY, et al.
Publicado: (2014)

Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015)

Abnormal differentiation of stem cells into enteroendocrine cells in rats with DSS-induced colitis
por: El-Salhy, Magdy, et al.
Publicado: (2017)

Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis
por: El-Salhy, Magdy, et al.
Publicado: (2016)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
por: Mazzawi, Tarek, et al.
Publicado: (2020)

Diet and Gastrointestinal Bypass–Induced Weight Loss: The Roles of Ghrelin and Peptide YY
por: Chandarana, Keval, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bipp44kiogi9ri8egak3r4c9o4